Similar articles

• Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.

  Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M. Magnusson P, et al. J Bone Miner Res. 1997 Feb;12(2):210-20. doi: 10.1359/jbmr.1997.12.2.210. J Bone Miner Res. 1997. PMID: 9041052 Clinical Trial.
• Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.

  Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L. Brixen K, et al. J Bone Miner Res. 1995 Dec;10(12):1865-74. doi: 10.1002/jbmr.5650101205. J Bone Miner Res. 1995. PMID: 8619366 Clinical Trial.
• Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.

  Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF. Kassem M, et al. J Bone Miner Res. 1994 Sep;9(9):1365-70. doi: 10.1002/jbmr.5650090907. J Bone Miner Res. 1994. PMID: 7817819 Clinical Trial.
• Biochemical markers of bone turnover: an update.

  van Daele PL, Birkenhäger JC, Pols HA. van Daele PL, et al. Neth J Med. 1994 Feb;44(2):65-72. Neth J Med. 1994. PMID: 8208326 Review.
• Skeletal effects of growth hormone and IGF-I in adults.

  Marcus R. Marcus R. Horm Res. 1997;48 Suppl 5:60-4. doi: 10.1159/000191330. Horm Res. 1997. PMID: 9434046 Review.